Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases—an updated systematic review
Abstract Background Cardiovascular diseases (CVDs) are the leading cause of mortality in India. Residual risk exists in patients receiving optimal guideline-directed medical therapy. Possession of certain somatic mutations, at a variant allele frequency of ≥ 2% in peripheral blood, driving clonal ex...
Main Authors: | Nagendra Boopathy Senguttuvan, Vinodhini Subramanian, Vettriselvi Venkatesan, T. R. Muralidharan, Kavitha Sankaranarayanan |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-07-01
|
Series: | Journal of Genetic Engineering and Biotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43141-021-00205-3 |
Similar Items
-
Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease
by: Yi-Chun Huang, et al.
Published: (2021-09-01) -
Clonal Hematopoiesis of Indeterminate Potential: A Multidisciplinary Challenge in Personalized Hematology
by: Gregor Hoermann, et al.
Published: (2020-08-01) -
JAK2V617F-positive clonal hematopoiesis of indeterminate potential in pregnant women
by: I. A. Olkhovskiy, et al.
Published: (2019-09-01) -
Myelodysplasia Syndrome, Clonal Hematopoiesis and Cardiovascular Disease
by: Camilla Bertuzzo Veiga, et al.
Published: (2021-04-01) -
Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review
by: Veronica Papa, et al.
Published: (2020-08-01)